Breakthrough in leukemia treatment comes at heavy cost

27 Oct 2014

1

A path-breaking new drug to treat leukaemia has given hope to patients as it kills nearly 90 per cent of their cancer in the first dose.

The drug Gazyva is so powerful it can send patients into shock – perhaps in more ways than one, as it comes with a whopping price tag of $42,000.

Though the drug has been approved for use in Australia, it is not yet subsidised by the Pharmaceutical Benefits Scheme. It also has some serious side effects including increased risk of infections, including lower white blood cell count and reduced ability of the blood to clot, as well as fever, cough, and muscle and joint pain.

A study published in the New England Journal of Medicine earlier this year showed  Gazyva delayed the progression of the  cancer  in patients using the  drug in combination with an older chemotherapy by 26.7 months, 15 months longer than progression-free survival in patients using standard treatment.

Business History Videos

History of hovercraft Part 3 | Industry study | Business History

History of hovercraft Part 3...

Today I shall talk a bit more about the military plans for ...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of hovercraft Part 2 | Industry study | Business History

History of hovercraft Part 2...

In this episode of our history of hovercraft, we shall exam...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Hovercraft Part 1 | Industry study | Business History

History of Hovercraft Part 1...

If you’ve been a James Bond movie fan, you may recall seein...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Trams in India | Industry study | Business History

History of Trams in India | ...

The video I am presenting to you is based on a script writt...

By Aniket Gupta | Presenter: Sheetal Gaikwad

view more
View details about the software product Informachine News Trackers